Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Biotech
Biotech
FDA slaps hold on 4DMT's phase 1/2 gene therapy trial
4D Molecular Therapeutics is on shaky ground as its Fabry disease gene therapy program has been hit with an FDA clinical hold.
Gabrielle Masson
Feb 3, 2023 1:28pm
Sanofi CEO plots path ‘back to the magic’ in oncology
Feb 3, 2023 11:12am
Fierce Biotech Layoff Tracker 2023: Eisai, Vyant and more
Feb 3, 2023 11:00am
New federal biotech commission taps 12 members—Chutes & Ladders
Feb 3, 2023 10:20am
Drug discovery biotech Vyant preps to wind down operations
Feb 3, 2023 10:14am
After 18-month hold, MaaT sees end to impasse with FDA
Feb 3, 2023 9:55am
